| scholarly article | Q13442814 |
| P2093 | author name string | En-Min Li | |
| Yi-Wei Xu | |||
| Yu-Hui Peng | |||
| Chao-Qun Hong | |||
| Can-Tong Liu | |||
| Xu-Chun Huang | |||
| P2860 | cites work | The immunobiology of cancer immunosurveillance and immunoediting | Q29616246 |
| Epstein-Barr virus: 40 years on | Q29617969 | ||
| Multivariate prognostic factor analysis in locally advanced and metastatic esophago-gastric cancer--pooled analysis from three multicenter, randomized, controlled trials using individual patient data | Q33203756 | ||
| The elevated preoperative platelet-to-lymphocyte ratio predicts poor prognosis in breast cancer patients | Q33613591 | ||
| Prognostic Factor Analysis of Overall Survival in Gastric Cancer from Two Phase III Studies of Second-line Ramucirumab (REGARD and RAINBOW) Using Pooled Patient Data | Q33849290 | ||
| Global incidence of oesophageal cancer by histological subtype in 2012. | Q34443765 | ||
| Classification of adenocarcinoma of the oesophagogastric junction | Q34755030 | ||
| Epstein-barr virus in gastro-esophageal adenocarcinomas - single center experiences in the context of current literature | Q35218805 | ||
| EBV-LMP1 targeted DNAzyme enhances radiosensitivity by inhibiting tumor angiogenesis via the JNKs/HIF-1 pathway in nasopharyngeal carcinoma | Q35742407 | ||
| Carbohydrate antigen 19-9 is a useful prognostic marker in esophagogastric junction adenocarcinoma | Q36358540 | ||
| Relationship between serum CA19-9 and CEA levels and prognosis of pancreatic cancer | Q36403838 | ||
| Prognostic value of preoperative mean corpuscular volume in esophageal squamous cell carcinoma | Q36841338 | ||
| Pretreatment Neutrophil to Lymphocyte Ratio Independently Predicts Disease-specific Survival in Resectable Gastroesophageal Junction and Gastric Adenocarcinoma | Q36999075 | ||
| An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. | Q37152934 | ||
| Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction | Q37391008 | ||
| Antiangiogenic and antitumoral effects mediated by a vascular endothelial growth factor receptor 1 (VEGFR-1)-targeted DNAzyme | Q37446015 | ||
| MicroRNAs in cancer: small molecules with a huge impact | Q37474280 | ||
| Prognostic significance of preoperative and postoperative CK19 and CEA mRNA levels in peripheral blood of patients with gastric cardia cancer | Q37672230 | ||
| Tissue factor and cancer | Q38048550 | ||
| Cancer-related inflammation | Q38066119 | ||
| Congenital fibrinogen disorders: an update. | Q38121515 | ||
| Tumour biomarkers: diagnostic, prognostic, and predictive | Q38542611 | ||
| Comparison of Prognostic Abilities Among Preoperative Laboratory Data Indices in Patients with Resectable Gastric and Esophagogastric Junction Adenocarcinoma | Q38663037 | ||
| Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual | Q38677496 | ||
| Significance of blood neutrophil-to-lymphocyte ratio for prognostic stratification of patients with gastroesophageal junction adenocarcinoma in the era of the 8th edition of the American Joint Committee on Cancer (AJCC8) staging. | Q38788398 | ||
| Esophagogastric Adenocarcinoma: Is More Chemotherapy Better? | Q38794776 | ||
| Analysis of esophagogastric cancer patients enrolled in the National Cancer Institute Cancer Therapy Evaluation Program sponsored phase 1 trials | Q38924049 | ||
| Systemic inflammatory markers and outcome in patients with locally advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction. | Q39029400 | ||
| Baseline neutrophil-lymphocyte ratio (NLR) is associated with survival and response to treatment with second-line chemotherapy for advanced prostate cancer independent of baseline steroid use. | Q39189394 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Prognostic value of neutrophil-to-lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial | Q40086094 | ||
| Effect of preoperative monocyte-lymphocyte ratio on prognosis of patients with resectable esophagogastric junction cancer | Q40286403 | ||
| Prognostic Role of a Multimarker Analysis of Circulating Tumor Cells in Advanced Gastric and Gastroesophageal Adenocarcinomas | Q40599089 | ||
| The prognostic value of preoperative inflammation-based prognostic scores and nutritional status for overall survival in resected patients with nonmetastatic Siewert type II/III adenocarcinoma of esophagogastric junction | Q42031892 | ||
| Presence of Epstein-Barr virus in esophageal cancer is restricted to tumor infiltrating lymphocytes | Q43701163 | ||
| Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer. | Q44106138 | ||
| Preoperative plasma hyperfibrinogenemia is predictive of poor prognosis in patients with nonmetastatic colon cancer | Q44335229 | ||
| Distinct recurrence pattern and outcome of adenocarcinoma of the gastric cardia in comparison with carcinoma of other regions of the stomach | Q44613235 | ||
| Esophageal squamous cell carcinomas arising in patients from a high-risk area of North China lack an association with Epstein-Barr virus | Q45745397 | ||
| Detection of Epstein-Barr virus in esophageal squamous cell carcinoma in Taiwan | Q45746778 | ||
| Circulating tumour DNA methylation markers for diagnosis and prognosis of hepatocellular carcinoma. | Q45945288 | ||
| Prognostic significance of targetable angiogenic and growth factors in patients undergoing resection for gastric and gastroesophageal junction cancers | Q46068781 | ||
| The role of systemic inflammatory and nutritional blood-borne markers in predicting response to neoadjuvant chemotherapy and survival in oesophagogastric cancer | Q46117374 | ||
| Prognostic factors influencing the survival of patients with carcinoma of the gastric cardia receiving preoperative interventional embolization chemotherapy | Q47152790 | ||
| Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab. | Q47323830 | ||
| Controlling Nutritional Status (CONUT) score is a prognostic marker for gastric cancer patients after curative resection. | Q47335538 | ||
| Change in Neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma. | Q49219959 | ||
| Validation of an assessment tool: Estimation of Postoperative Overall Survival for Gastric Cancer | Q50052723 | ||
| The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction. | Q50281305 | ||
| A nationwide retrospective study of perioperative chemotherapy for gastroesophageal adenocarcinoma: tolerability, outcome, and prognostic factors. | Q50353991 | ||
| Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study. | Q50860920 | ||
| Prognostic impact of preoperative platelets to lymphocytes ratio (PLR) on survival for oesophageal and junctional carcinoma treated with neoadjuvant chemotherapy: A retrospective monocentric study on 153 patients. | Q50884320 | ||
| Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. | Q51048207 | ||
| Clinical practice. Barrett's esophagus. | Q51764391 | ||
| Palliative stenting for oesophagogastric cancer: tumour and host factors and prognosis. | Q53077328 | ||
| Methylation-mediated downregulation of long noncoding RNA LOC100130476 in gastric cardia adenocarcinoma. | Q53099225 | ||
| MicroRNA signature predicts survival and relapse in lung cancer. | Q53507653 | ||
| Infectious Mononucleosis | Q56115612 | ||
| Esophageal Cancer | Q56209683 | ||
| Epstein-Barr Virus and Cancer | Q59354256 | ||
| Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries | Q60142201 | ||
| High Mean Corpuscular Volume Predicts Poor Outcome for Patients With Gastroesophageal Adenocarcinoma | Q64236861 | ||
| [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients] | Q70507813 | ||
| Prognostic nutritional index in gastrointestinal surgery | Q71128739 | ||
| Aetiology and classification of adenocarcinoma of the gastro-oesophageal junction/cardia | Q83145734 | ||
| Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer | Q85728374 | ||
| Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction | Q86069055 | ||
| The preoperative neutrophil-lymphocyte ratio predicts recurrence and survival among patients undergoing R0 resections of adenocarcinomas of the esophagogastric junction | Q88007308 | ||
| The pro-inflammatory role of platelets in cancer | Q88188494 | ||
| Preoperative monocyte-lymphocyte and neutrophil-lymphocyte but not platelet-lymphocyte ratios are predictive of clinical outcomes in resected patients with non-metastatic Siewert type II/III adenocarcinoma of esophagogastric junction: a prospective | Q88997602 | ||
| Combination of preoperative fibrinogen and neutrophil to lymphocyte ratio is a predictive prognostic factor in ESCC and AEG systematic review | Q90068488 | ||
| Autoantibodies: Potential clinical applications in early detection of esophageal squamous cell carcinoma and esophagogastric junction adenocarcinoma | Q90318254 | ||
| High neutrophil-to-lymphocyte ratio (NLR) is associated with treatment failure and death in patients who have melanoma treated with PD-1 inhibitor monotherapy | Q90481410 | ||
| Prognostic significance of preoperative albumin-to-globulin ratio and prognostic nutritional index combined score in Siewert type 3 adenocarcinoma of esophagogastric junction | Q90731759 | ||
| The combination of preoperative fibrinogen and neutrophil-lymphocyte ratio is a predictive prognostic factor in esophagogastric junction and upper gastric cancer | Q90837552 | ||
| C-reactive protein/albumin ratio is a poor prognostic factor of esophagogastric junction and upper gastric cancer | Q91006451 | ||
| Immune-related Genes to Dominate Neutrophil-lymphocyte Ratio (NLR) Associated With Survival of Cetuximab Treatment in Metastatic Colorectal Cancer | Q91464895 | ||
| [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum] | Q91868637 | ||
| Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer | Q92365439 | ||
| Tumour-associated neutrophils in patients with cancer | Q92502928 | ||
| Identification of combined T-cell and B-cell reactive Echinococcus granulosus 95 antigens for the potential development of a multi-epitope vaccine | Q92593664 | ||
| High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma | Q92696309 | ||
| [Value of Glasgow prognostic score in patients with adenocarcinoma of esophagogastric junction] | Q95543830 | ||
| P433 | issue | 15 | |
| P304 | page(s) | 4332-4342 | |
| P577 | publication date | 2020-04-27 | |
| P1433 | published in | Journal of Cancer | Q6294901 |
| P1476 | title | Blood-based Markers in the Prognostic Prediction of Esophagogastric Junction Cancer | |
| P478 | volume | 11 |
Search more.